Table 4 Proportions of cardiometabolic medications
Medication | Frequency |
|---|---|
Hypoglycaemic | |
Insulin | 23% (109/473) |
Metformin | 76.7% (415/473) |
Other oral Hypoglycaemics | 87.7% (415/473) |
Hypolipidaemic | 65.1% (308/473) |
Statins | 62.8% (297/473) |
Fibrate | 2.7% (13/473) |
Ezetimibe | 4.2% (20/473) |
Antihypertensives | 71.5% (338/473) |
Beta blocker | 18.6% (88/473) |
ACEi | 40.2% (190/473) |
ARB | 33.8% (160/473) |
Antiplatelets | 46.9% (222/473) |
Aspirin | 44.2% (209/473) |
Dipyridamole | 1.3% (6/473) |
Clopidogrel | 4.9% (23/473) |
Warfari | 5.9% (28/473 |